Jazz Pharmaceuticals plc

By person

36 insiders · 483 transactions

34.4×

Renee D. Gala holds 34.4 times base salary in stock. $34.55M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Renee D. Gala last reported holding, valued at $240.94, the price Ordinary Shares was last bought or sold at on the open market here, on 10 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

COZADD BRUCE C

Director

—

$69.94M (133) scheduled

−$69.94M

351,875

0.5421%

$84.78M

+21.8%

Mulligan Seamus

Director

$22.77M (13)

—

+$22.77M

1,286,254

1.98%

$309.91M

+22.7%

Iannone Robert

EVP, Global Head of R&D & CMO

—

$22.01M (11) scheduled

−$22.01M

65,686

0.1012%

$15.83M

+4,629%

Patil Neena M

EVP & Chief Legal Officer

—

$14.28M (24) scheduled

−$14.28M

47,671

0.0734%

$11.49M

+3,726%

ENRIGHT PATRICK G

Director

—

$6.41M (21)

−$6.41M

21,278

0.0328%

$5.13M

+25.0%

Winningham Rick E

Director

—

$6.18M (14) scheduled

−$6.18M

9,466

0.0146%

$2.28M

−30.8%

Carr Patricia

SVP, Chief Accounting Officer

—

$5.83M (44) scheduled

−$5.83M

6,512

0.0100%

$1.57M

+17.0%

Pearce Samantha

EVP, Chief Commercial Officer

—

$4.92M (12) scheduled

−$4.92M

47,131

0.0726%

$11.36M

+5,806%

Hooper Suzanne Sawochka

EVP & General Counsel

—

$4.24M (8)

−$4.24M

39,738

0.0612%

$9.57M

+6.7%

O'Keefe Kenneth W

Director

$227.69K (3)

$4.03M (14)

−$3.80M

30,256

0.0466%

$7.29M

+207.2%

WILSON KAREN J

SVP, Finance & PAO

—

$3.17M (6) scheduled

−$3.17M

18,385

0.0283%

$4.43M

+6.6%

Young Matthew P.

EVP & CFO

—

$3.14M (23)

−$3.14M

36,200

0.0558%

$8.72M

+6.0%

McSharry Heather Ann

Director

—

$2.98M (11) scheduled

−$2.98M

18,199

0.0280%

$4.38M

+199.5%

Sohn Catherine A.

Director

—

$2.88M (10) scheduled

−$2.88M

14,868

0.0229%

$3.58M

+143.1%

RIEDEL NORBERT G

Director

—

$2.86M (10) scheduled

−$2.86M

17,553

0.0270%

$4.23M

+254.4%

Gray Peter

Director

—

$2.16M (8) scheduled

−$2.16M

16,068

0.0248%

$3.87M

+137.9%

GALA RENEE D

President & CEO

—

$1.70M (3)

−$1.70M

143,394

0.2209%

$34.55M

+10,084%

Treacy Paul

SVP, Technical Operations

—

$1.61M (13)

−$1.61M

16,418

0.0253%

$3.96M

+12.5%

Henderson Mary Elizabeth

SVP, Technical Operations

—

$1.57M (3)

−$1.57M

23,815

0.0367%

$5.74M

—

MILLER MICHAEL PATRICK

EVP, US Commercial

—

$1.51M (28)

−$1.51M

22,118

0.0341%

$5.33M

+20.5%

Johnson Philip L

EVP & Chief Financial Officer

$1.44M (1)

—

+$1.44M

56,431

0.0869%

$13.60M

+8,745%

Sablich Kim

EVP, GM of U.S.

—

$1.37M (9)

−$1.37M

28,478

0.0439%

$6.86M

—

BERNS PAUL L

Director

—

$1.36M (9)

−$1.36M

8,290

0.0128%

$2.00M

+58.4%

Larkin Finbar

SVP, Technical Operations

—

$1.29M (13)

−$1.29M

21,779

0.0336%

$5.25M

+126.1%

McGill Iain

SVP, Europe & Rest of World

—

$1.07M (1) scheduled

−$1.07M

24,938

0.0384%

$6.01M

+35.4%

Tovey Christopher J.

EVP, COO & Managing Director E

—

$833.44K (2) scheduled

−$833.44K

14,663

0.0226%

$3.53M

+58,552%

Smith Mark Douglas

Director

—

$769.36K (6)

−$769.36K

9,579

0.0148%

$2.31M

—

Schnee Elmar

Director

—

$663.90K (6)

−$663.90K

8,270

0.0127%

$1.99M

+59.8%

Cox Russell J.

EVP & COO

—

$515.00K (2)

−$515.00K

102,821

0.1584%

$24.77M

+100.3%

Cook Jennifer E.

Director

—

$502.62K (5)

−$502.62K

10,736

0.0165%

$2.59M

—

ORiordan Anne

Director

—

$406.74K (4)

−$406.74K

16,500

0.0254%

$3.98M

—

Swisher Daniel N JR

President and COO

—

55,014

0.0847%

$13.26M

+5,778%

Smith Karen L.

EVP, R&D and CMO

—

28,474

0.0439%

$6.86M

+98.3%

Hamill Laura

Director

—

6,832

0.0105%

$1.65M

+355.5%

Kennedy Patrick

Director

—

6,452

0.0099%

$1.55M

—

LOVE TED W

Director

—

2,389

0.0037%

$575.61K

—

Jazz Pharmaceuticals plc

By person

Individual transactions

What was left out